As a case presented in this article neonatal abstinence syndrome (NAS) occurs following prenatal opioid exposure. These drugs have been associated with numerous obstetrical complications including intrauterine growth restriction, placental abruption, preterm delivery, stillbirth, and maternal death. NAS is characterized by signs and symptoms indicating central nervous system hyperirritability and autonomic nervous system, gastrointestinal tract. Symptoms of NAS typcall occurs following prenatal opioid exposure 48-72 hours post-birth. Blood, hair, urine or meconium confirmation may assist the diagnosis of NAS. The Finnegan scoring system is commonly used to assess the severity of NAS. Scoring can be helpful for initiating, monitoring, and terminating treatment in neonates.

Keywords: neonatal, abstinence syndrome, opioid